Some antiphospholipid antibodies recognize conformational epitopes shared by β2-glycoprotein I and the homologous catalytic domains of several serine proteases

Arthritis and Rheumatism

Volumn 56, Issue 5, 2007, Pages 1638-1647

  Lin, Wei Shiang ^a,b   Chen, Pei Chih ^b   Yang, Cheng Be ^b   Cho, Eunjung ^b   Hahn, Bevra H ^b   Grossman, Jennifer ^b   Hwang, Kwan Ki ^b   Chen, Pojen P ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; AUTOANTIGEN; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CROSS REACTING ANTIBODY; CYCLOPHOSPHAMIDE; DROTRECOGIN; EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; PLASMIN; PREDNISOLONE; RITUXIMAB; SERINE PROTEINASE; THROMBIN; WARFARIN;

ADULT; ANAMNESIS; ANTIBODY AFFINITY; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONFORMATIONAL TRANSITION; CROSS REACTION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENZYME ACTIVE SITE; ENZYME BINDING; FEMALE; HEMOSTASIS; HUMAN; IMMUNOREACTIVITY; LUNG EMBOLISM; LUNG HEMORRHAGE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCREENING; SUBDURAL HEMATOMA;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BLOOD COAGULATION FACTORS; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN G; PLASMIN; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; SERINE ENDOPEPTIDASES; THROMBIN;

EID: 34248523994     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22522     Document Type: Article

References (43)

1. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42: 1309-11.
2. Lockshin MD, Sammaritano L, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000;43:440-3.
3. Levine J, Branch D, Rauch J. Medical progress: the antiphospholipid syndrome. N Engl J Med 2002;346:752-63.
4. Passam F, Krilis S. Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology 2004;36:129-38.
5. De Groot PG, Derksen RH. Antiphospholipid antibodies: update on detection, pathophysiology, and treatment. Curr Opin Hematol 2004;11:165-9.
6. Mackworth-Young CG. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 2004;136:393-401.
7. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
8. Harris EN, Pierangeli SS. Antiphospholipid antibodies and the antiphospholipid syndrome. Springer Semin Immunopathol 1994; 16:223-45.
9. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
10. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990;87: 4120-4.
11. Fleck RA, Rapaport SI, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512-9.
12. Bevers EM, Galli M, Barui T, Comfurius P, Zwaal RF. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991;66:629-32.
13. Oosting JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 1993;81:2618-25.
14. 2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus 2002;11:215-20.
15. Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997;337:154-60.
16. Rand JH, Wu XX, Lapinski R, van Heerde WL, Reutelingsperger CP, Chen PP, et al. Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood 2004;104:2783-90.
17. Hwang KK, Grossman JM, Visvanathan S, Chukwuocha RU, Woods VL, Le DT, et al. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J Immunol 2001;167: 7192-8.
18. Lollar P. Pathogenic antibodies to coagulation factors. II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor. J Thromb Haemost 2005;3:1385-91.
19. Hwang KK, Yang CD, Yan W, Grossman JM, Hahn BH, Chen PP. A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C. Arthritis Rheum 2003;48:1622-30.
20. Yang CD, Hwang KK, Yan W, Gallagher K, FitzGerald J, Grossman JM, et al. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J Immunol 2004;172:5765-73.
21. Cugno M, Dominguez M, Cabibbe M, Bisiani G, Galli M, Angles-Cano E, et al. Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome. Br J Haematol 2000;108:871-5.
22. Cugno M, Cabibbe M, Galli M, Meroni PL, Caccia S, Russo R, et al. Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. Blood 2004;103:2121-6.
23. Lu CS, Horizon AA, Hwang KK, FitzGerald J, Lin WS, Hahn BH, et al. Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum 2005;52:4018-27.
24. Roubey RA, Hoffman M. From antiphospholipid syndrome to antibody-mediated thrombosis. Lancet 1997;350:1491-3.
25. Permpikul P, Rao LV, Rapaport SI. Functional and binding studies of the roles of prothrombin and β-glycoprotein I in the expression of lupus anticoagulant activity. Blood 1994;83: 2878-92.
26. St Charles R, Matthews JH, Zhang E, Tulinsky A. Bound structures of novel P3-P1′ β-strand mimetic inhibitors of thrombin. J Med Chem 1999;42:1376-83.
27. Mather T, Oganessyan V, Hof P, Huber R, Foundling S, Esmon C, et al. The 2.8 A crystal structure of Gla-domainless activated protein C. EMBO J 1996;15:6822-31.
28. Wang X, Lin X, Loy JA, Tang J, Zhang XC. Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science 1998;281:1662-5.
29. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward A, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983;301:214-21.
30. Olee TW, Pierangeli SS, Handley HH, Le DT, Wei X, Lai CJ, et al. A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice. Proc Natl Acad Sci U S A 1996;93:8606-11.
31. Carroll WL, Thielemans K, Dilley J, Levy R. Mouse x human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods 1986;89:61-72.
32. 2GP1 antibodies from two patients with the antiphospholipid syndrome reveals three species of antibodies. Br J Haematol 1999;105:102-9.
33. Zhao Y, Rumold R, Zhu M, Zhou D, Ahmed AE, Le DT, et al. An IgG antiprothrombin antibody enhances prothrombin binding to damaged endothelial cells and shortens plasma coagulation times. Arthritis Rheum 1999;42:2132-8.
34. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 1985;77:305-19.
35. Harpel PC, Sullivan R, Chang TS. Binding and activation of plasminogen on immobilized immunoglobulin G: identification of the plasmin-derived Fab as the plasminogen-binding fragment. J Biol Chem 1989;264:616-24.
36. Chuba JV. Susceptibility of monoclonal IgG paraproteins to plasmic cleavage using glycerin-stabilized human plasmin. Biochem Biophys Res Commun 1994;202:367-3.
37. Miesbach W, Matthias T, Scharrer I. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Ann N Y Acad Sci 2005;1050:250-6.
38. 2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display. J Immunol 1999; 163:4604-11.
39. 2-gfycoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndrome. J Autoimmun 2006;26:57-65.
40. 2-glycoprotein 1 and preserved during species' evolution. J Immunol 1996;157:5732-8.
41. Pierangeli SS, Liu XW, Espinola R, Olee T, Zhu M, Harris NE, et al. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost 2000;84:388-95.
42. Pierangeli SS, Barker JH, Stikovac D, Ackerman D, Anderson G, Barquinero J, et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994;71:670-4.
43. Rand JH, Wu XX, Quinn AS, Chen PP, McCrae KR, Bovill EG, et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol 2003;163:1193-200.